Effects of isoflavones on the pelvic floor and the periurethral vascularization of postmenopausal women;Efeitos das isoflavonas sobre o assoalho pélvico e a vascularização peri-uretral de mulheres na pós-menopausa

Revista Brasileira de Ginecologia e Obstetricia

Volumn 28, Issue 9, 2006, Pages 545-550

  Accorsi, Leni Aparecida Spagna ^a   Haidar, Mauro Abi ^a   Simões, Ricardo Santos ^a   Neto, Alfeu Cornélio Accorsi ^b   Mosquette, Rejane ^a   Soares Jr , José Maria ^a,d   Baracat, Edmund Chada ^a,c  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^b Faculdade de Medicina de Catanduva   (Brazil)

^c UNIVERSITY OF SÃO PAULO   (Brazil)

^d NONE   (Brazil)

Author keywords

Isoflavone therapeutic use; Laser doppler flowmetry; Pelvic floor; Postmenopause; Urethra drug effects physiology ultrasonography

Indexed keywords

EID: 33846828181     PISSN: 01007203     EISSN: None     Source Type: Journal    
DOI: 10.1590/S0100-72032006000900007     Document Type: Article

References (26)

1. Masse PG, Tranchant CC, Dosy J, Donovan SM. Coexistence of osteoporosis and cardiovascular disease risk factors in apparently healthy, untreated postmenopausal women. Int J Vitam Nutr Res. 2005;75(2):97-106.
2. Iosif CS, Bekassy Z. Prevalence of genito-urinary symptoms in the late menopause. Acta Obstet Gynecol Scand. 1984;63(3):257-60.
3. Sirola J, Rikkonen T. Muscle performance after the menopause. J Br Menopause Soc. 2005;11(2):45-50.
4. Thompson LV. Effects of age and training on skeletal muscle physiology and performance. Phys Ther. 1994;74(1):71-81.
5. Chmel R, Novackova M, Vlk R, Horcicka L. [Epidemiological aspects of the female urinary incontinence]. Cas Lek Cesk. 2005;144(2):95-7. Review. Czech.
6. Contreras Ortiz O, Coya Nuñez F, Ibañez G. [Evaluación funcional del piso pelviano femenino (classificación funcional)]. Bol Soc Latinoam Uroginecol Cir Vaginal. 1994;1(1):5-9. Spanish.
7. Moreira ECH. Valor da avaliação propedêutica objetiva e subjetiva no diagnóstico da incontinência urinária feminina: correlação com a força muscular do assoalho pélvico. Rev Bras Ginecol Obstet. 2000;22(9):597.
8. Branca F, Lorenzetti S. Health effects of phytoestrogens. Forum Nutr. 2005;(57):100-11.
9. Han KK, Soares JM Jr, Haidar MA, de Lima GR, Baracat EC. Benefits of soy isoflavone therapeutic regimen on menopausal symptoms. Obstet Gynecol. 2002;99(3):389-94.
10. Kaari C, Haidar MA, Junior JM, Nunes MG, Quadros LG, Kemp C, et al. Randomized clinical trial comparing conjugated equine estrogens and isoflavones in postmenopausal women: a pilot study. Maturitas. 2006;53(1):49-58.
11. Lamartiniere CA. Protection against breast cancer with genistein: a component of soy. Am J Clin Nutr. 2000;71(6 Suppl):1705S-7S.
12. Zhu L, Lang J, Feng R, Chen J, Wong F. Estrogen receptor in pelvic floor tissues in patients with stress urinary incontinence. Int Urogynecol J Pelvic Floor Dysfunct. 2004;15(5):340-3.
13. Girão MJ, Jarmy-Di Bella ZI, Sartori MG, Baracat EC, Lima GR. Doppler velocimetry parameters of periurethral vessels in postmenopausal incontinent women receiving estrogen replacement. Int Urogynecol J Pelvic Floor Dysfunct. 2001;12(4):241-6.
14. Long CY, Liu CM, Hsu SC, Chen YH, Wu CH, Tsai EM. A randomized comparative study of the effects of oral and topical estrogen therapy on the lower urinary tract of hysterectomized postmenopausal women. Fertil Steril. 2006;85(1):155-60.
15. Contreras Ortiz O, Coya Nuñez F. Dynamic assessment of pelvic floor functionin women using the intravaginal device test. Int Urogynecol J Pelvic FloorDysfunct. 1996;7(6):317-20.
16. Silva Filho CR, Baracat EC, Conterno LO, Haidar MA, Ferraz MB. Climacteric symptoms and quality of life: validity of women's health questionnaire. Rev Saúde Publica. 2005;39(3):333-9.
17. Girão MBC, Sartori MGF, Baracat EC, Lima GR. Cirurgia vaginal e uroginecologia. 2a ed. Porto Alegre: Artes Médicas; 2002. p. 105-34.
18. Sartori MG, Girão MJ, de Jesus Simões M, Sartori JP, Baracat EC, Rodrigues de Lima G. Quantitative evaluation of collagen and muscle fibers in the lower urinary tract of castrated and under-hormone replacement female rats. Clin Exp Obstet Gynecol. 2001;28(2):92-6.
19. Cardozo L, Lose G, McClish D, Versi E. A systematic review of the effects of estrogens for symptoms suggestive of overactive bladder. Acta Obstet Gynecol Scand. 2004;83(10):892-7.
20. Slomczynska M. The effect of phytoestrogens on the reproductive tract. Pol J Vet Sci. 2004;7(3):223-6.
21. Glazer HI, Romanzi L, Polaneczky M. Pelvic floor muscle surface electromyography. Reliability and clinical predictive validity. J Reprod Med. 1999;44(9):779-82.
22. Klarskov P, Belving D, Bischoff N, Dorph S, Gerstenberg T, Okholm B, et al. Pelvic floor exercise versus surgery on the female urinary stress incontinence. Urol Int. 1986;41(2):129-32.
23. Battaglia C, Mancini F, Persico N, Penacchioni P, Regnani G, Volpe A, et al. Tibolone, oral or transdermal hormone replacement and colour Doppler analysis: a prospective, randomised pilot study. Maturitas. 2004;48(4):446-55.
24. Trompezinski S, Denis A, Schmitt D, Viac J. Comparative effects of polyphenols from green tea (EGCG) and soybean (genistein) on VEGF and IL-8 release from normal human keratinocytes stimulated with the proinflammatory cytokine TNFalpha. Arch Dermatol Res. 2003;295(3):112-6.
25. Chin-Dusting JP, Boak L, Husband A, Nestel PJ. The isoflavone metabolite dehydroequol produces vasodilatation in human resistance arteries via a nitric oxide-dependent mechanism. Atherosclerosis. 2004;176(1):45-8.
26. Woodman OL, Missen MA, Boujaoude M. Daidzein and 17 beta-estradiol enhance nitric oxide synthase activity associated with an increase in calmodulin and a decrease in caveolin-1. J Cardiovasc Pharmacol. 2004;44(2):155-63.